---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management and improve patient outcomes, today announced the publication of a study validating performance of a novel algorithm designed to integrate the DecisionDx ® -Melanoma gene expression profile (GEP) test with clinicopathologic features (i31-GEP SLNB) to determine sentinel lymph node biopsy (SLNB) positivity risk in patients with cutaneous melanoma."
publishedDateTime: 2021-11-05T21:01:00Z
originalUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
webUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
type: article
quality: 11
heat: 11
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "hH32UYO5K51Q6JgeLG3C2c9kHItMmAnU1BizTuRFPMixa7+ZhGwpPFtksbSGaVegFepCtZj+mvRdPb9a6tqZF8FEpArOuHL1mWJJNJvHtv9c/wkpREkG5lNBm+BuMk2Jm9IBCYAZhGtUEOtktaXfjZzkM80ol9Y6P3ls22cqEu0zSwbYMm13/TwImIliw0Obl2IFfVuWDKvBsazF+FCwkAKNmUB52DDgpmR6TKFATyDdg6lAqOB7EF0p+LjpLIivxHzFpoya71hTGxFIUV0hizvRs5vqTjK5bHeg4ZEXpXuUSdbAWILkfmR39uWGEW8MVKyqkn8N647n5imsF8hxqd5zreIdBE+JXDk2NaxAQh8=;bLX+TiJCwp1OJFIcav7Yjg=="
---

